NK cells in the clinic workshop in Madrid

NK cells in the clinic workshop in Madrid

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

The symposium ‘MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY’, has a waiting list. Please let us know if you do not plan to attend in person, so that we can accommodate everyone.

The event will be held at the Spanish National Centre for Biotechnology (CNB-CSIC) in Madrid, March 5-6, 2026 and will bring together researchers, clinicians and industry experts, offering a unique platform to share recent efforts in innovation on advanced therapies.

The scientific sessions will include keynote talks by international scientists and clinicians, experts in the transfer of new therapies to the clinic and industry. As a novelty, we will have several roundtables in which invited specialists will discuss other crucial aspects to consider when planning translational research such as regulatory issues, how to work in a clean room and business aspects. Talks and roundtables will include these topics:

Talks by experts: Tumour recognition by NK cells, NK cell enhancer biomolecules, Successful NK cell-based therapies in the clinics

Roundtable 1: Regulatory aspects: how to understand guidelines for experimental design, how to reach regulatory agencies

Roundtable 2: The clean room and therapeutics production

Roundtable 3: Advanced therapies from the lab to industry. Science, investment and business aspects

More information for attendees (venue, cafeterias on campus) and the program can be found in these links

Latest Updates

Grantee name: Simona Kranjc BrezarStart and end date: 1.4.2026-31.5.2026 During my two-month STSM at IPBS Toulouse, I gained hands-on experience in spectral flow cytometry and intravital microscopy for studying immune...
Conference title: ESMO Immuno-Oncology Congress 2025Conference web-page: https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2025 Conference venue: Queen Elizabeth II Centre in London, United Kingdom. Conference start and end date: 10/12/2025 to 12/12/2025 Title of the presentation:...
Training in techniques for generating patient-derived immuno-oncology models from squamous cell carcinomas I am Norbert Nass, investigator at Brandenburg Medical School (MHB), Institute of Pathology in Brandenburg / Havel, Germany....
Attending the 3R Länd Conference in Tübingen, Germany, with the support of the YRI IMMUNO-model grant was a valuable opportunity to learn about cutting-edge alternatives to animal testing and their...
In the scope of 1 month long STSM at the Science for life laboratory in Stockholm, Sweden, we combined advanced 3D glioblastoma models and different regions of glioblastoma tissue with...
Title: Engineered immune-competent models of metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma using patient-derived hepatocyte organoids and biomaterials Start and end date: 16/02/2026 to 17/04/2026 I am Ana Margarida...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter